Janes, A. (2024) “Aducanumab: The Controversial New Drug Licensed to Treat Alzheimer’s Disease”, Trinity Student Medical Journal , 22(1), pp. 6–11. Available at: https://esr.ie/index.php/tsmj/article/view/2811 (Accessed: 21 February 2026).